QCX · Retrograde Intubation Set
Anesthesiology · 21 CFR 868.5095 · Class 2
Overview
| Product Code | QCX |
|---|---|
| Device Name | Retrograde Intubation Set |
| Regulation | 21 CFR 868.5095 |
| Device Class | Class 2 |
| Review Panel | Anesthesiology |
| 3rd-Party Reviewable | Yes |
Identification
A retrograde intubation device is a prescription device used to perform retrograde intubation via the cricothyroid membrane. The device may contain or be labeled for use with guidewires and intubating catheters, in addition to needles (§ 868.5090), syringe (§ 880.5860 of this chapter), and hemostats (§ 878.4800 of this chapter).
Classification Rationale
Class II (special controls). The special controls for this device are:
Special Controls
In combination with the general controls of the FD&C Act, the retrograde intubation device is subject to the following special controls: - (1) Non-clinical performance testing must demonstrate that the device performs as intended under anticipated conditions of use, including the following: - A. Wire guide tensile, flex, fracture, and corrosion testing; - B. Catheter tensile strength testing at likely points of failure; - C. Catheter kink radius testing: - D. Compatibility of device components that interact, including compatibility in connection, disconnection, and ability to transfer fluids; - E. Dimensional validation; - F. Accuracy testing of markings; - G. Validation of the maximum airway pressure. - (2) Performance data must support the shelf life of the device by demonstrating continued sterility, package integrity, and device functionality over the identified shelf life. - (3) The device must be demonstrated to be biocompatible. - (4) Labeling must include: - A. Instructions for use; and - B. Package labels that clearly identify the minimum compatible size of endotracheal tube.
*Classification.* Class II (special controls). The special controls for this device are:(1) Non-clinical performance testing must demonstrate that the device performs as intended under anticipated conditions of use, including the following: (i) Wire guide tensile, flex, fracture, and corrosion testing; (ii) Catheter tensile strength testing at likely points of failure; (iii) Catheter kink radius testing; (iv) Compatibility of device components that interact, including compatibility in connection, disconnection, and ability to transfer fluids; (v) Dimensional validation; (vi) Accuracy testing of markings; and (vii) Validation of the maximum airway pressure. (2) Performance data must support the shelf life of the device by demonstrating continued sterility, package integrity, and device functionality over the identified shelf life. (3) The device must be demonstrated to be biocompatible. (4) Labeling must include: (i) Instructions for use; and (ii) Package labels that clearly identify the minimum compatible size of endotracheal tube.
Cleared Devices (1)
| Record | Device Name | Applicant | Decision Date | Decision |
|---|---|---|---|---|
| DEN170055 | Retrograde Intubation Set | Cook Incorporated | Dec 12, 2018 | DENG |
Top Applicants
- Cook Incorporated — 1 clearance
